New statistical frameworks such as net treatment benefit offer a multidimensional approach to evaluating efficacy, safety, and patient-centered outcomes in oncology trials.
Rudradev Sengupta
Advertisement
Senior Trial Design Lead at One2Treat
Articles by Rudradev Sengupta
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Honing the Power of AI for Next Generation Trial Oversight and Execution
2
AstraZeneca’s Phase III POTOMAC Trial Shows Imfinzi Significantly Improves Disease-Free Survival in High-Risk NMIBC
3
Verzenio and Kisqali Deliver Positive Long-Term Results in Early Breast Cancer Trials
4
Accelerating Development Through Parallel Execution and Rigorous Quality Controls
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
